Hillrom Acquires Bardy Diagnostics
January 19, 2021
Hillrom (NYSE: HRC) agreed to acquire Bardy Diagnostics, Inc. (BardyDx) for $375 million in cash plus potential milestone payments, expanding Hillrom's digital health and ambulatory cardiac monitoring capabilities. The deal brings Hillrom a wearable ECG platform (the CAM patch), approximately $30 million in annualized revenue, and about 230 employees; Hillrom expects the acquisition to be dilutive in year one and accretive thereafter.
- Buyers
- Hillrom
- Targets
- Bardy Diagnostics, Inc.
- Industry
- Medical Devices
- Location
- United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
ARCHIMED Diagnostics Acquires 60% Stake in ARK Diagnostics
October 28, 2025
Medical Devices
ARCHIMED Diagnostics (ARCHIMED’s diagnostics team) has acquired a 60% stake in Fremont-based ARK Diagnostics from Soulbrain Holdings in a transaction valuing ARK at $428 million. Soulbrain retains and reinvests in a 40% stake and the deal includes a joint-venture agreement to accelerate ARK’s product development and global expansion.
-
CardioOne Acquires CardioDiagnostics
April 24, 2025
Healthcare Services
CardioOne, a national growth and operational partner for independent cardiology practices, has acquired CardioDiagnostics, a provider of advanced ECG and remote patient monitoring (RPM) technologies. The deal integrates CardioDiagnostics’ cloud-based monitoring, analytics and RPM capabilities into CardioOne’s practice management platform to expand virtual care and enhance cardiology practice services.
-
Quest Diagnostics Acquires Haystack Oncology
April 27, 2023
Healthcare Services
Quest Diagnostics has agreed to acquire Haystack Oncology in an all-cash transaction valued at $300 million at closing plus up to $150 million in potential milestones. The acquisition adds Haystack's sensitive ctDNA-based minimal residual disease (MRD) liquid biopsy technology to Quest's oncology, genomics and pathology capabilities to expand clinical lab services for MRD testing beginning in 2024.
-
Baxter International Acquires Hillrom
December 13, 2021
Healthcare Services
Baxter International completed its acquisition of Hillrom, creating a global medtech leader with an enterprise value of about $12.5 billion (including assumed debt). Baxter paid $156.00 in cash per Hillrom share, aiming to expand connected care, digital health innovation, and global market reach for Hillrom’s portfolio.
-
Hologic, Inc. Acquires Mobidiag Oy
June 17, 2021
Medical Devices
Hologic, Inc. has completed the acquisition of Mobidiag Oy, a Finnish developer of near‑patient molecular diagnostic instruments and tests, for approximately $808 million. The deal expands Hologic's diagnostics capabilities by adding Mobidiag's Amplidiag and Novodiag platforms for rapid, multiplexed acute‑care testing and broadens Hologic's global diagnostics footprint.
-
Royal Philips to Acquire BioTelemetry, Inc. for $2.8B
December 18, 2020
Healthcare Services
Royal Philips has agreed to acquire BioTelemetry, Inc. in a cash tender offer of USD 72.00 per share, implying an enterprise value of approximately USD 2.8 billion. The deal combines Philips' hospital patient-monitoring capabilities with BioTelemetry's remote cardiac diagnostics and monitoring services (which serve over 1 million patients annually and had 2019 sales of about USD 439 million) to expand Philips' patient care management offerings across hospital and home settings.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.